BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11155748)

  • 1. Intracellular delivery of membrane-impermeable hydrophilic molecules to a hepatoblastoma cell line by asialoglycoprotein-labeled liposomes.
    Yu HY; Lin JH
    J Formos Med Assoc; 2000 Dec; 99(12):936-41. PubMed ID: 11155748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-mediated transfer of pSV2CAT DNA to a human hepatoblastoma cell line HepG2 using asialofetuin-labeled cationic liposomes.
    Hara T; Aramaki Y; Takada S; Koike K; Tsuchiya S
    Gene; 1995 Jul; 159(2):167-74. PubMed ID: 7542617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopharmaceutical evaluation of the liposomes prepared by rehydration of freeze-dried empty liposomes (FDELs) with an aqueous solution of a drug.
    Yachi K; Harashima H; Kikuchi H; Sudo R; Yamauchi H; Ebihara K; Matsuo H; Funato K; Kiwada H
    Biopharm Drug Dispos; 1996 Oct; 17(7):589-605. PubMed ID: 8894117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific uptake of asialofetuin-tacked liposomes encapsulating interferon-gamma by human hepatoma cells and its inhibitory effect on hepatitis B virus replication.
    Ishihara H; Hayashi Y; Hara T; Aramaki Y; Tsuchiya S; Koike K
    Biochem Biophys Res Commun; 1991 Jan; 174(2):839-45. PubMed ID: 1704230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents.
    Wu J; Liu P; Zhu JL; Maddukuri S; Zern MA
    Hepatology; 1998 Mar; 27(3):772-8. PubMed ID: 9500706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes.
    Arangoa MA; Düzgüneş N; Tros de Ilarduya C
    Gene Ther; 2003 Jan; 10(1):5-14. PubMed ID: 12525832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes.
    Hara T; Kuwasawa H; Aramaki Y; Takada S; Koike K; Ishidate K; Kato H; Tsuchiya S
    Biochim Biophys Acta; 1996 Jan; 1278(1):51-8. PubMed ID: 8611607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of asialofetuin-labeled liposomes with encapsulated human interferon-gamma and their uptake by isolated rat hepatocytes.
    Ishihara H; Hara T; Aramaki Y; Tsuchiya S; Hosoi K
    Pharm Res; 1990 May; 7(5):542-6. PubMed ID: 1694992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of 3H-cholesteryl ether labeled liposomes following intravenous administration to mice: comparison with an encapsulated 14C-inulin as aqueous phase marker.
    Anderson M; Paradis C; Omri A
    Drug Deliv; 2003; 10(3):193-200. PubMed ID: 12944140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes.
    Kawakami S; Yamashita F; Nishikawa M; Takakura Y; Hashida M
    Biochem Biophys Res Commun; 1998 Nov; 252(1):78-83. PubMed ID: 9813149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of charged liposomes by the rat liver.
    Yu HY; Lin CY
    J Formos Med Assoc; 1997 Jun; 96(6):409-13. PubMed ID: 9216162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular delivery of drugs by liposomes containing P0 glycoprotein from peripheral nerve myelin into human M21 melanoma cells.
    Foldvari M; Mezei C; Mezei M
    J Pharm Sci; 1991 Nov; 80(11):1020-8. PubMed ID: 1726112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells.
    Maitani Y; Kawano K; Yamada K; Nagai T; Takayama K
    J Control Release; 2001 Aug; 75(3):381-9. PubMed ID: 11489324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.
    Managit C; Kawakami S; Yamashita F; Hashida M
    J Pharm Sci; 2005 Oct; 94(10):2266-75. PubMed ID: 16136555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient gene transfer to hepatoblastoma cells through asialoglycoprotein receptor and expression under the control of the cyclin A promoter.
    Aramaki Y; Lee I; Arima H; Sakamoto T; Magami Y; Yoshimoto T; Moriyasu F; Mizuguchi J; Koyanagi Y; Nikaido T; Tsuchiya S
    Biol Pharm Bull; 2003 Mar; 26(3):357-60. PubMed ID: 12612447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UPTAKE OF LIPOSOMES WHICH INCORPORATE A GLYCOPEPTIDE FRACTION OF ASIALOFETUIN BY HepG(2) CELLS.
    Kallinteri P; Papadimitriou E; Antimisiaris SG
    J Liposome Res; 2001; 11(2-3):175-93. PubMed ID: 19530932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of diethylenetriaminepentaacetic acid conjugated inulin and utility for cellular uptake of liposomes.
    Essien H; Lai JY; Hwang KJ
    J Med Chem; 1988 May; 31(5):898-901. PubMed ID: 3361577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of drug-carrier liposomes by placenta: transplacental delivery of drugs and nutrients.
    Tüzel-Kox SN; Patel HM; Kox WJ
    J Pharmacol Exp Ther; 1995 Jul; 274(1):104-9. PubMed ID: 7616385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the hepatocytic cell targetability of liposomes].
    Hou XP; Wang L; Wang XT; Li S
    Yao Xue Xue Bao; 2003 Feb; 38(2):143-6. PubMed ID: 12778752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific incorporation of asialofetuin-labeled liposomes into hepatocytes through the action of galactose-binding protein.
    Hara T; Aramaki Y; Tsuchiya S; Hosoi K; Okada A
    Biopharm Drug Dispos; 1987; 8(4):327-39. PubMed ID: 2441770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.